Structure of IDP00348

1.95 Angstrom crystal structure of a bifunctional 3-deoxy-7-phosphoheptulonate synthase/chorismate mutase (aroA) from Listeria monocytogenes EGD-e in complex with phosphoenolpyruvate

Edit deposit information
CSGID target
IDP00348 
PDB Id
3TFC (NCBI MMDB
Authors
'S.H.Light,G.Minasov,A.S.Halavaty,L.Shuvalova,K.Kwon,W.F.Anderson,Center For Structural Genomics Of Infectious Diseases (Csgid)' 
Responsible person
Sam Light 
Responsible lab
Northwestern University 
Deposition Date
Aug 15, 2011 
Release Date
Aug 31, 2011 

Annotation

Description
The shikimate pathway links metabolism of carbohydrates to biosynthesis of aromatic compounds. In a sequence of seven steps, phosphoenolpyruvate and erythrose 4-phosphate are converted to chorismate, a precursor of the aromatic amino acids and many secondary aromatic metabolites. The shikimate pathway is essential for most bacteria and plants but absent in humans, making it an attractive target for the development of novel antibiotics. 3-deoxy-7-phosphoheptulonate DAHP synthase catalyzes the conversion of phosphoenolpyruvate and D-erythrose 4-phosphate to DAHP, the first step in the shikimate pathway. Chorismate mutase catalyzes the conversion of chorismate, the shikimate pathway’s endproduct, to prephenate. Prephenate is a precursor for the aromatic amino acids phenylalanine and tyrosine. While structures of individual DAHP and chorismate mutase domains have been previously solved, this structure is the first to characterize this natural bifunctional protein which is found in a subset of bacteria. This structure reveals that the DAHP synthase domains are assembled into their typical physiological tetrameric state. The N-terminal chorismate mutase domains emerge from either side of the tetramer and after a lengthy linker region form a pair of dimers which sandwich the tetrameric core. The linker region between the DAHP and chorismate mutase domains acts differently within the two molecules within the asymmetric unit - a result which may be due to crystal packing. In this structure, phosphoenolpyruvate, which was added to the crystallization mixture, is observed at the active site.  
Functional assignment
 

Ligands

Ligand code Name Ligand type
PEP phosphoenolpyruvate biological
MN biological
175 3,5-dihydro-5-methylidene-4h-imidazol-4-on

Structure information

Unit cell parameters

Space Group
C 1 2 1  
Unit Cell

a=110.16Å, b=110.89Å, c=80.23Å
α=90.00, β=127.21, γ=90.00 
Solvent content
 
Matthews coefficient
 

Refinement

Data for the highest resolution shell is in parentheses.
Resolution range
30.00-1.95Å (1.99-1.94Å)  
Rall(%)
17.6 
Rwork(%)
17.5 (24.4) 
Rfree(%)
20.5 (27.0) 
Num. observed reflections
55389 (3223) 
Num. Rfree reflections
2824 (175) 
Completeness(%)
97.6 (78.4) 

Model parameters

Num Atoms
5312  
Num Waters
352  
Num Hetatoms
378  
Model mean isotropic B factor
32.270Å2  
RMSD bond length
0.007Å  
RMSD bond angle
1.183°  
Filename uploaded
3TFC.pdb (uploaded on Jun 05, 2015 5:01 PM)  
Inserted
Aug 16, 2011